• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Food

  • Print
  • Share
  • E-mail

Bisphenol A (BPA)

 

On this page:


Overview & Updates

BPA (Bisphenol A) is a chemical used in certain food contact materials and first approved by FDA in the early 1960s. In recent years, concerns have been raised about BPA's safety.

In August 2008, FDA released a draft report finding that BPA remains safe in food contact materials. On October 31, 2008, a subcommittee of FDA's science board raised questions about whether FDA's review had adequately considered the most recent scientific information available. See additional information on assessments and the science board.

On January 15, 2010 and again updated in March 2012 and March 2013, FDA issued an update on BPA, inlcuding FDA's perspective. The update also includes information on:

  • Additional Studies
  • Public Comment and Next Steps for FDA's Assessment of BPA
  • Interim Public Health Recommendations
  • The Regulatory Framework for BPA
  • Collaboration with International Partners.
     

For FAQs, see Questions & Answers on Bisphenol A (BPA) Use in Food Contact Applications

For additional consumer information, see Consumer Update: FDA Continues to Study BPA

For recommendations for the public, see Bisphenol A (BPA) Information for Parents on the Department of Health and Human Services Web site. 

 

Response to Petition on BPA

On October 28, 2008, the Natural Resources Defense Council (NRDC) submitted a citizen petition regarding BPA. The petition requested that the Commissioner of Food and Drugs:

  • Issue a regulation prohibiting the use of BPA in human food and packaging, and
  • Revoke all regulations permitting the use of any food additive that may result in BPA becoming a component of food.

On March 30, 2012, the FDA denied this request in accordance with 21 CFR 10.30(e)(3). In its response, the FDA stated that:

  • The information provided in the citizen petition was not sufficient to persuade FDA to initiate this rulemaking.
  • The most appropriate course of action at this time is to continue scientific study and review of all new evidence regarding the safety of BPA.
  • Although FDA was not persuaded by the data and information in the NRDC citizen petition to initiate rulemaking to revoke the food additive approvals for BPA, FDA will continue in its broader and more comprehensive review of emerging data and information on BPA. Depending on the results, any of these studies or data could influence FDA’s assessment and future regulatory decisions about BPA.

See Letter to Natural Resources Defense Council - Petition Denial

  

-

Additional Information from FDA about BPA and Food Contact Substances

-
-

Other Official Assessments

-